Page 642 - Hematology_ Basic Principles and Practice ( PDFDrive )
P. 642

545.e6  Part V  Red Blood Cells


        229.  Imhoff-Kunsch B, Flores R, Dary O, et al: Wheat flour fortification is   254.  Pittschieler S, Brezinka C, Jahn B, et al: Spontaneous abortion and the
            unlikely to benefit the neediest in Guatemala. J Nutr 137:1017–1022,   prophylactic effect of folic acid supplementation in epileptic women
            2007.                                                 undergoing antiepileptic therapy. J Neurol 255:1926–1931, 2008.
        230.  Craig WJ, Mangels AR: Position of the American Dietetic Association:   255.  Rehman HU: Vitamin B12 deficiency causing night sweats. Scott Med
            vegetarian diets. J Am Diet Assoc 109:1266–1282, 2009.  J 59:e8–e11, 2014.
        231.  Titaley CR, Dibley MJ, Roberts CL, et al: Combined iron/folic acid   256.  Sherley-Dale AC, Goulding JM, Leithead J, et al: Pigmentary changes
            supplements and malaria prophylaxis reduce neonatal mortality in 19   in pernicious anaemia: an important but under-recognized phenom-
            sub-Saharan African countries. Am J Clin Nutr 92:235–243, 2010.  enon. Clin Exp Dermatol 36:93–95, 2011.
        232.  Okebe JU, Yahav D, Shbita R, et al: Oral iron supplements for children   257.  Agrawala  RK,  Sahoo  SK,  Choudhury  AK,  et al:  Pigmentation  in
            in malaria-endemic areas. Cochrane Database Syst Rev (10):CD006589,   vitamin B12 deficiency masquerading Addison’s pigmentation: a rare
            2011.                                                 presentation. Indian J Endocrinol Metab 17:S254–S256, 2013.
        233.  Dhar M, Bellevue R, Carmel R: Pernicious anemia with neuropsychi-  258.  Vannella L, Lahner E, Osborn J, et al: Systematic review: gastric cancer
            atric dysfunction in a patient with sickle cell anemia treated with folate   incidence in pernicious anaemia. Aliment Pharmacol Ther 37:375–382,
            supplementation. N Engl J Med 348:2204–2207, 2003.    2013.
        234.  Mahadeo KM, Diop-Bove N, Ramirez SI, et al: Prevalence of a loss-  259.  Jauhar S, Blackett A, Srireddy P, et al: Pernicious anaemia presenting
            of-function  mutation  in  the  proton-coupled  folate  transporter  gene   as catatonia without signs of anaemia or macrocytosis. Br J Psychiatry
            (PCFT-SLC46A1)  causing  hereditary  folate  malabsorption  in  Puerto   197:244–245, 2010.
            Rico. J Pediatr 159:623–627 e1, 2011.             260.  Mavrommati  K,  Sentissi  O:  Delirium  as  a  result  of  vitamin  B12
        235.  Borzutzky  A,  Crompton  B,  Bergmann  AK,  et al:  Reversible  severe   deficiency in a vegetarian female patient. Eur J Clin Nutr 67:996–997,
            combined  immunodeficiency  phenotype  secondary  to  a  mutation  of   2013.
            the  proton-coupled  folate  transporter.  Clin  Immunol  133:287–294,   261.  Field  MS,  Kamynina  E,  Watkins  D,  et al:  Human  mutations  in
            2009.                                                 methylenetetrahydrofolate  dehydrogenase  1  impair  nuclear  de  novo
        236.  Min SH, Oh SY, Karp GI, et al: The clinical course and genetic defect   thymidylate biosynthesis. Proc Natl Acad Sci USA 112:400–405, 2015.
            in  the  PCFT  gene  in  a  27-year-old  woman  with  hereditary  folate   262.  Shah NP, Beech CM, Sturm AC, et al: Investigation of the ABC trans-
            malabsorption. J Pediatr 153:435–437, 2008.           porter MRP1 in selected patients with presumed defects in vitamin B12
        237.  Bermejo  F,  Algaba  A,  Guerra  I,  et al:  Should  we  monitor  vitamin   absorption. Blood 117:4397–4398, 2011.
            B12 and folate levels in Crohn’s disease patients? Scand J Gastroenterol   263.  Rajan S, Wallace JI, Brodkin KI, et al: Response of elevated methylma-
            48:1272–1277, 2013.                                   lonic acid to three dose levels of oral cobalamin in older adults. J Am
        238.  Visentin M, Diop-Bove N, Zhao R, et al: The intestinal absorption of   Geriatr Soc 50:1789–1795, 2002.
            folates. Annu Rev Physiol 76:251–274, 2014.       264.  Allen RH, Stabler SP: Identification and quantitation of cobalamin and
        239.  McFarland  R:  Cerebral  folate  deficiency—mishaps  and  misdirection.   cobalamin analogues in human feces. Am J Clin Nutr 87:1324–1335,
            Brain 135:2002–2003, 2012.                            2008.
        240.  Perez-Duenas B, Ormazabal A, Toma C, et al: Cerebral folate deficiency   265.  Auerbach M, Pappadakis JA, Bahrain H, et al: Safety and efficacy of
            syndromes in childhood: clinical, analytical, and etiologic aspects. Arch   rapidly  administered  (one  hour)  one  gram  of  low  molecular  weight
            Neurol 68:615–621, 2011.                              iron dextran (INFeD) for the treatment of iron deficient anemia. Am J
        241.  de Haan W: A folate receptor defect that causes treatable neurological   Hematol 86:860–862, 2011.
            disorder in children. Clin Genet 77:435–436, 2010.  266.  Mellemkjaer  L,  Gridley  G,  Moller  H,  et al:  Pernicious  anaemia  and
        242.  Ramaekers VT, Rothenberg SP, Sequeira JM, et al: Autoantibodies to   cancer risk in Denmark. Br J Cancer 73:998–1000, 1996.
            folate receptors in the cerebral folate deficiency syndrome. N Engl J Med   267.  Wilcox AJ, Lie RT, Solvoll K, et al: Folic acid supplements and risk
            352:1985–1991, 2005.                                  of  facial  clefts:  national  population  based  case-control  study.  BMJ
        243.  Gordon N: Cerebral folate deficiency. Dev Med Child Neurol 51:180–  334:464, 2007.
            182, 2009.                                        268.  Jacques PF, Selhub J, Bostom AG, et al: The effect of folic acid fortifica-
        244.  Ramaekers  VT,  Blau  N,  Sequeira  JM,  et al:  Folate  receptor  autoim-  tion on plasma folate and total homocysteine concentrations. N Engl J
            munity and cerebral folate deficiency in low-functioning autism with   Med 340:1449–1454, 1999.
            neurological deficits. Neuropediatrics 38:276–281, 2007.  269.  Ganji V, Kafai MR: Hemoglobin and hematocrit values are higher and
        245.  Frye RE, Sequeira JM, Quadros EV, et al: Cerebral folate receptor auto-  prevalence of anemia is lower in the post-folic acid fortification period
            antibodies  in  autism  spectrum  disorder.  Mol  Psychiatry  18:369–381,   than in the pre-folic acid fortification period in US adults. Am J Clin
            2013.                                                 Nutr 89:363–371, 2009.
        246.  Sadighi Z, Butler IJ, Koenig MK: Adult-onset cerebral folate deficiency.   270.  Crider KS, Bailey LB, Berry RJ: Folic acid food fortification-its history,
            Arch Neurol 69:778–779, 2012.                         effect, concerns, and future directions. Nutrients 3:370–384, 2011.
        247.  Berrocal-Zaragoza MI, Fernandez-Ballart JD, Murphy MM, et al: Asso-  271.  Yi Y, Lindemann M, Colligs A, et al: Economic burden of neural tube
            ciation between blocking folate receptor autoantibodies and subfertility.   defects and impact of prevention with folic acid: a literature review. Eur
            Fertil Steril 91:1518–1521, 2009.                     J Pediatr 170:1391–1400, 2011.
        248.  Bliek  JB,  Rothenberg  SP,  Steegers-Theunissen  RP:  Maternal  folate   272.  Robbins  JM,  Cleves  MA,  Collins  HB,  et al:  Randomized  trial  of  a
            receptor autoantibodies and cleft lip and/or palate. Int J Gynaecol Obstet   physician-based intervention to increase the use of folic acid supple-
            93:142–143, 2006.                                     ments among women. Am J Obstet Gynecol 192:1126–1132, 2005.
        249.  O’Leary  VB,  Parle-McDermott  A,  Molloy  AM,  et al:  MTRR  and   273.  Paudel  P,  Wing  K,  Silpakar  SK:  Awareness  of  periconceptional  folic
            MTHFR polymorphism: link to Down syndrome?  Am J Med Genet   acid supplementation among Nepalese women of childbearing age: a
            107:151–155, 2002.                                    cross-sectional study. Prev Med 55:511–513, 2012.
        250.  Christensen KE, Rozen R: Genetic variation: effect on folate metabo-  274.  Worthington-White DA, Behnke M, Gross S: Premature infants require
            lism and health. In Bailey LB, editor: Folate in health and disease, ed 2,   additional folate and vitamin B-12 to reduce the severity of the anemia
            Boca Raton, FL, 2010, CRC Press.                      of prematurity. Am J Clin Nutr 60:930–935, 1994.
        251.  Huemer  M,  Ausserer  B,  Graninger  G,  et al:  Hyperhomocysteinemia   275.  Strober  BE,  Menon  K:  Folate  supplementation  during  methotrexate
            in children treated with antiepileptic drugs is normalized by folic acid   therapy for patients with psoriasis. J Am Acad Dermatol 53:652–659,
            supplementation. Epilepsia 46:1677–1683, 2005.        2005.
        252.  Apeland T, Mansoor MA, Pentieva K, et al: The effect of B-vitamins   276.  Whittle  SL,  Hughes  RA:  Folate  supplementation  and  methotrexate
            on hyperhomocysteinemia in patients on antiepileptic drugs. Epilepsy   treatment  in  rheumatoid  arthritis:  a  review.  Rheumatology  (Oxford)
            Res 51:237–247, 2002.                                 43:267–271, 2004.
        253.  George L, Mills JL, Johansson AL, et al: Plasma folate levels and risk   277.  Osei AK, Rosenberg IH, Houser RF, et al: Community-level micronu-
            of spontaneous abortion. JAMA 288:1867–1873, 2002.    trient fortification of school lunch meals improved vitamin A, folate,
   637   638   639   640   641   642   643   644   645   646   647